134 related articles for article (PubMed ID: 18275847)
1. Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1.
Katsuki Y; Sakamoto K; Minamizato T; Makino H; Umezawa A; Ikeda MA; Perbal B; Amagasa T; Yamaguchi A; Katsube K
Biochem Biophys Res Commun; 2008 Apr; 368(3):808-14. PubMed ID: 18275847
[TBL] [Abstract][Full Text] [Related]
2. CCN3 and DLL1 co-regulate osteogenic differentiation of mouse embryonic fibroblasts in a Hey1-dependent manner.
Su X; Wei Y; Cao J; Wu X; Mou D; Luo J; Li A; Zuo GW; Tang M
Cell Death Dis; 2018 Dec; 9(12):1188. PubMed ID: 30538222
[TBL] [Abstract][Full Text] [Related]
3. CCN3/NOV inhibits BMP-2-induced osteoblast differentiation by interacting with BMP and Notch signaling pathways.
Minamizato T; Sakamoto K; Liu T; Kokubo H; Katsube K; Perbal B; Nakamura S; Yamaguchi A
Biochem Biophys Res Commun; 2007 Mar; 354(2):567-73. PubMed ID: 17250806
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation.
Bleau AM; Planque N; Lazar N; Zambelli D; Ori A; Quan T; Fisher G; Scotlandi K; Perbal B
J Cell Biochem; 2007 Aug; 101(6):1475-91. PubMed ID: 17340618
[TBL] [Abstract][Full Text] [Related]
5. NOV/CCN3 impairs muscle cell commitment and differentiation.
Calhabeu F; Lafont J; Le Dreau G; Laurent M; Kazazian C; Schaeffer L; Martinerie C; Dubois C
Exp Cell Res; 2006 Jun; 312(10):1876-89. PubMed ID: 16600215
[TBL] [Abstract][Full Text] [Related]
6. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression.
Fu CT; Bechberger JF; Ozog MA; Perbal B; Naus CC
J Biol Chem; 2004 Aug; 279(35):36943-50. PubMed ID: 15213231
[TBL] [Abstract][Full Text] [Related]
7. The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway.
Sakamoto K; Yamaguchi S; Ando R; Miyawaki A; Kabasawa Y; Takagi M; Li CL; Perbal B; Katsube K
J Biol Chem; 2002 Aug; 277(33):29399-405. PubMed ID: 12050162
[TBL] [Abstract][Full Text] [Related]
8. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type.
Benini S; Perbal B; Zambelli D; Colombo MP; Manara MC; Serra M; Parenza M; Martinez V; Picci P; Scotlandi K
Oncogene; 2005 Jun; 24(27):4349-61. PubMed ID: 15824736
[TBL] [Abstract][Full Text] [Related]
9. The aminoterminal insulin-like growth factor (IGF) binding domain of IGF binding protein-3 cannot be functionally substituted by the structurally homologous domain of CCN3.
Yan X; Baxter RC; Perbal B; Firth SM
Endocrinology; 2006 Nov; 147(11):5268-74. PubMed ID: 16935848
[TBL] [Abstract][Full Text] [Related]
10. NOV/CCN3 induces adhesion of muscle skeletal cells and cooperates with FGF2 and IGF-1 to promote proliferation and survival.
Lafont J; Thibout H; Dubois C; Laurent M; Martinerie C
Cell Commun Adhes; 2005; 12(1-2):41-57. PubMed ID: 16371345
[TBL] [Abstract][Full Text] [Related]
11. Expression of CCN3 protein in human Wilms' tumors: immunohistochemical detection of CCN3 variants using domain-specific antibodies.
Subramaniam MM; Lazar N; Navarro S; Perbal B; Llombart-Bosch A
Virchows Arch; 2008 Jan; 452(1):33-9. PubMed ID: 18066593
[TBL] [Abstract][Full Text] [Related]
12. CCN3 and bone marrow cells.
Katsube K; Ichikawa S; Katsuki Y; Kihara T; Terai M; Lau LF; Tamamura Y; Takeda S; Umezawa A; Sakamoto K; Yamaguchi A
J Cell Commun Signal; 2009 Jun; 3(2):135-45. PubMed ID: 19626464
[TBL] [Abstract][Full Text] [Related]
13. Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins.
Planque N; Long Li C; Saule S; Bleau AM; Perbal B
J Cell Biochem; 2006 Sep; 99(1):105-16. PubMed ID: 16598765
[TBL] [Abstract][Full Text] [Related]
14. Osteogenic differentiation of mouse mesenchymal progenitor cell, Kusa-A1 is promoted by mammalian transcriptional repressor Rbpj.
Wang S; Kawashima N; Sakamoto K; Katsube K; Umezawa A; Suda H
Biochem Biophys Res Commun; 2010 Sep; 400(1):39-45. PubMed ID: 20691157
[TBL] [Abstract][Full Text] [Related]
15. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.
Doghman M; Arhatte M; Thibout H; Rodrigues G; De Moura J; Grosso S; West AN; Laurent M; Mas JC; Bongain A; Zambetti GP; Figueiredo BC; Auberger P; Martinerie C; Lalli E
J Clin Endocrinol Metab; 2007 Aug; 92(8):3253-60. PubMed ID: 17566092
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
17. Promotion of dentin regeneration via CCN3 modulation on Notch and BMP signaling pathways.
Wang X; He H; Wu X; Hu J; Tan Y
Biomaterials; 2014 Mar; 35(9):2720-9. PubMed ID: 24406215
[TBL] [Abstract][Full Text] [Related]
18. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
[TBL] [Abstract][Full Text] [Related]
19. The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor.
Böhlig L; Metzger R; Rother K; Till H; Engeland K
Cell Cycle; 2008 May; 7(9):1254-61. PubMed ID: 18418052
[TBL] [Abstract][Full Text] [Related]
20. The role of connective tissue growth factor in skeletal growth and development.
Kanaan RA; Aldwaik M; Al-Hanbali OA
Med Sci Monit; 2006 Dec; 12(12):RA277-281. PubMed ID: 17136017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
